Cargando…
Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
Ovarian cancer (OC) is the most lethal gynecologic malignancy, affecting approximately 1 in 70 women with only 45% surviving 5 years after diagnosis. This disease typically presents at an advanced stage, and optimal debulking with platinum-based chemotherapy remains the cornerstone of management. Al...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710491/ https://www.ncbi.nlm.nih.gov/pubmed/34966689 http://dx.doi.org/10.3389/fonc.2021.795547 |